87 related articles for article (PubMed ID: 23818345)
1. The role of ThinPrep cytology in the investigation of ki-67 index, p53 and HER-2 detection in fine-needle aspirates of breast tumors.
Konofaos P; Kontzoglou K; Parakeva P; Kittas C; Margari N; Giaxnaki E; Pouliakis M; Kouraklis G; Karakitsos P
J BUON; 2013; 18(2):352-8. PubMed ID: 23818345
[TBL] [Abstract][Full Text] [Related]
2. The role of ThinPrep cytology in the evaluation of estrogen and progesterone receptor content of breast tumors.
Konofaos P; Kontzoglou K; Georgoulakis J; Megalopoulou T; Zoumpouli C; Christoni Z; Papadopoulos O; Kouraklis G; Karakitsos P
Surg Oncol; 2006 Dec; 15(4):257-66. PubMed ID: 17451941
[TBL] [Abstract][Full Text] [Related]
3. Primary breast carcinoma: immunocytochemical and immunohistochemical evaluation of biological parameters.
Sianesi M; Bozzetti C; Del Rio P; Nizzoli R; Cascinu S
Chir Ital; 2000; 52(6):643-5. PubMed ID: 11199998
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 expression on fine-needle aspirates from primary breast carcinoma: correlation with other biologic factors.
Bozzetti C; Nizzoli R; Naldi N; Guazzi A; Camisa R; Bella MA; Cocconi G
Cancer; 1999 Aug; 87(4):224-30. PubMed ID: 10455211
[TBL] [Abstract][Full Text] [Related]
5. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
6. Hormone receptor and human epidermal growth factor receptor 2 status evaluation on ThinPrep specimens from breast carcinoma: correlation with histologic sections determination.
Pegolo E; Machin P; Riosa F; Bassini A; Deroma L; Di Loreto C
Cancer Cytopathol; 2012 Jun; 120(3):196-205. PubMed ID: 22298467
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas.
Nizzoli R; Bozzetti C; Naldi N; Guazzi A; Gabrielli M; Michiara M; Camisa R; Barilli A; Cocconi G
Cancer; 2000 Feb; 90(1):61-6. PubMed ID: 10692218
[TBL] [Abstract][Full Text] [Related]
8. [Role of Ki-67, mutated gene-suppressor p53 and HER-2neu oncoprotein in the prognosis for the clinical course of bladder cancer].
Masliukova EA; Pozharisskiĭ KM; Karelin MI; Startsev VIu; Ten VP
Vopr Onkol; 2006; 52(6):643-8. PubMed ID: 17338241
[TBL] [Abstract][Full Text] [Related]
9. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
Rudolph P; Alm P; Olsson H; Heidebrecht HJ; Fernö M; Baldetorp B; Parwaresch R
Hum Pathol; 2001 Mar; 32(3):311-9. PubMed ID: 11274641
[TBL] [Abstract][Full Text] [Related]
10. HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.
Beatty BG; Bryant R; Wang W; Ashikaga T; Gibson PC; Leiman G; Weaver DL
Am J Clin Pathol; 2004 Aug; 122(2):246-55. PubMed ID: 15323142
[TBL] [Abstract][Full Text] [Related]
11. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen.
Railo M; Nordling S; Krogerus L; Sioris T; von Smitten K
Diagn Cytopathol; 1996 Sep; 15(3):205-10. PubMed ID: 8955602
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer.
Yamashita H; Nishio M; Toyama T; Sugiura H; Zhang Z; Kobayashi S; Iwase H
Breast Cancer Res; 2004; 6(1):R24-30. PubMed ID: 14680497
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.
Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
J BUON; 2013; 18(2):366-71. PubMed ID: 23818347
[TBL] [Abstract][Full Text] [Related]
14. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: a pilot study.
Flezar MS; Kirbis IS; Popović KS; Strojan P
Radiother Oncol; 2009 Dec; 93(3):575-80. PubMed ID: 19850367
[TBL] [Abstract][Full Text] [Related]
16. Correlation of HER-2/neu protein overexpression with other prognostic and predictive factors in invasive ductal breast cancer.
Ivkovic-Kapicl T; Knezevic-Usaj S; Djilas-Ivanovic D; Panjkovic M
In Vivo; 2007; 21(4):673-8. PubMed ID: 17708365
[TBL] [Abstract][Full Text] [Related]
17. Fine needle aspiration cytology of benign breast disease. Markers of apoptosis and proliferation.
Swiatecka J; Laudański P; Dziecioł J
Neoplasma; 2004; 51(1):49-55. PubMed ID: 15004660
[TBL] [Abstract][Full Text] [Related]
18. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features.
Perrone G; Santini D; Vincenzi B; Zagami M; La Cesa A; Bianchi A; Altomare V; Primavera A; Battista C; Vetrani A; Tonini G; Rabitti C
Histopathology; 2005 May; 46(5):561-8. PubMed ID: 15842638
[TBL] [Abstract][Full Text] [Related]
19. Identification of a chemoprevention cohort from a population of women at high risk for breast cancer.
Fabian CJ; Kamel S; Zalles C; Kimler BF
J Cell Biochem Suppl; 1996; 25():112-22. PubMed ID: 9027607
[TBL] [Abstract][Full Text] [Related]
20. HER-2 positive and p53 negative breast cancers are associated with poor prognosis.
Al-azawi D; Leong S; Wong L; Kay E; Hill AD; Young L
Cancer Invest; 2011 Jun; 29(5):365-9. PubMed ID: 21599513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
